发明名称 |
METHOD FOR DETERMINING INDICATIONS FOR IMMUNE SUPPRESSIVE THERAPY FOLLOWING PENETRATING KERATOPLASTY |
摘要 |
FIELD: medicine.SUBSTANCE: what is presented is a method for determining indications for immune suppressive therapy following penetrating keratoplasty. Keratoplasty is preceded by determining a level of interleukin-2 (IL-2) in supernatants of recipient's lymphocyte cell cultures both stimulated and not stimulated by PHA; and the absence of a reliable difference in the IL-2 levels, the immune suppressive therapy is not considered to be indicated.EFFECT: invention enables predicting a patient's preoperative immune response on a transplant and determining an adequacy of the immune suppressive therapy.2 ex |
申请公布号 |
RU2471195(C1) |
申请公布日期 |
2012.12.27 |
申请号 |
RU20110145686 |
申请日期 |
2011.11.11 |
申请人 |
FEDERAL'NOE GOSUDARSTVENNOE BJUDZHETNOE UCHREZHDENIE "MOSKOVSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ INSTITUTGLAZNYKH BOLEZNEJ IMENI GEL'MGOL'TSA" MINISTERSTVA ZDRAVOOKHRANENIJA I SOTSIAL'NOGO RAZVITIJA ROSSIJSKOJ FEDERATSII |
发明人 |
SLEPOVA OL'GA SEMENOVNA;MIRONKOVA ELENA ALEKSANDROVNA;MAKAROV PAVEL VASIL'EVICH;KUGUSHEVA ANNA EHDUARDOVNA |
分类号 |
G01N33/53 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|